4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-22-018292
Chief Medical Officer sold 4,000 shares at $60.90 ($243,600)
- Chief Medical Officer acquired 4,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2022-10-03 | Option exercise | +4,000 | $24.90 | $99,600 | 4,000 | D: show line 1 in the form |
| Garren Hideki Chief Medical Officer | 2022-10-03 | Sale | −4,000 | $60.90 | $243,600 | 0 | D: show line 2 in the form |
| Open-market sales · 4,000 sh · avg $60.90 · $243,600 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Garren Hideki Chief Medical Officer | 2022-10-03 | Option exercise · Stock Option (Right to Buy) | −4,000 | 230,000 | D: show line 3 in the form |
Loading xslF345X03/doc1.xml…